albuterol
Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange |
---|---|---|---|---|---|---|
ProAir HFA, Proventil HFA, Ventolin HFA | AEROSOL, INHALATION | CFC free 90 mcg/inh | ||||
Proventil, Ventolin | SOLUTION, INHALATION | 2.5 mg/3 mL (0.083%), 5 mg/mL | ||||
Ventolin | SYRUP, ORAL | 2 mg/5 mL | ||||
VoSpire ER, Volmax | TABLET, EXTENDED RELEASE, ORAL | 4 mg, 8 mg | ||||
Proventil | TABLET, ORAL | 2 mg, 4 mg |
Due to national shortage of the nebulization solutions, the formulary status of inhaler products has been temporarily adjusted to formulary, restricted to use during the albuterol/Duoneb shortage. Upon shortage resolution, these products will automatically return to their original formulary status. See Albuterol/Duoneb Shortage Mitigation for more information. (Updated Feb 2023)
NOTICE:
After emergency conference call with physicians, nursing, and pharmacy leaders it was approved to use albuterol inhalers for suspected, presumptive positive and positive COVID-19 patients. All others will continue to observe the formulary interchange to nebulization as listed.
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
albuterol MDI (Ventolin HFA, ProAir HFA, Proventil HFA) **ADULT PRN Orders**
albuterol (Proventil, Ventolin)
albuterol ER oral (VOSPIRE ER, VOLMAX)
albuterol IR oral (PROVENTIL)
Common Nebulized Doses for Pediatrics
August 23, 2006 -- Automatic albuterol INH to levalbuterol INH interchange program discontinued.
22 March 2016 -- Long-acting albuterol oral is non-formulary with an automatic interchange to IR.